NEW YORK (GenomeWeb) – CombiMatrix announced today that it has selected Cryoport as its cryogenic logistics partner for the distribution of its CombiPGS preimplantantion genetic screening test for women undergoing in vitro fertilization.

According to CombiMatrix, Cryport handles the shipment of frozen eggs, embryos, and sperm for the reproductive medicine market throughout the US and in more than 80 countries worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.